Skip to main content
. 2017 Dec 12;9(1):743–754. doi: 10.18632/oncotarget.23142

Figure 4. OCT3 mediates cisplatin resistance in hepatoma cells.

Figure 4

(A) mRNA expression in CpROCT3 cells and CpR cells. Mean/SE are given (n = 3). (B) Densitometric analysis of OCT3 protein expression as determined by Western blot. ATP7B KO cells were set to 100%. Mean/SE are given (n = 3). (C) OCT3 function was assessed by ASP+ uptake rates. Mean/SE are given (n = 3). (D) Cell viability was determined by MTT assay relative to untreated cells (100%). Mean/SE are given (n = 5). *P < 0.05.